|
Maria Luisa Palmese joined Kenyon & Kenyon in 1990. She focuses primarily on patent litigation, mainly in the chemical, pharmaceutical, and biological fields. Representative cases she has been involved in include:
Merck & Co. v. Teva Pharmaceutical U.S.A., Inc. (D. Del. 2003) (osteoporosis medication)
De Simone v. Vesely (D.D.C. 2002) (probiotics)
Merck & Co. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2001) (osteoporosis medication)
Revlon v. Estee Lauder (S.D.N.Y. 2000) (cosmetic emulsions)
American Home Products v. Medeva Pharma (D.Del.2000) (vaccine)
Cordant Technologies, Inc. v. Alliant Techsystems, Inc. (D. Del. 1998) (rocket motor insulation)
Eli Lilly and Co. v. American Cyanamid Co. (S.D. Ind. 1995) (antibiotic)
Hoechst v. Warner Lambert (D. Del. 1993) (Alzheimer’s disease medication)
Ms. Palmese also has extensive experience in patent prosecution in various fields, including pharmaceuticals, nutritional products, agricultural machinery, mosaic design, and roofing. In addition Ms. Palmese regularly counsels clients on validity, enforceability and infringement issues, as well as licensing and due diligence investigations. She also has a keen interest in the protection of trademarks and designs, and has counseled clients regarding trademark and design protection. Her thesis for her LLM degrees from Munich Intellectual Property center in Munich, Germany, is "Much Ado, Yet Nothing Done About Design Protection in the U.S.: Has The Time Finally Come for a U.S. Design Law?" Ms. Palmese is bilingual in English and Italian, and fluent in French and Spanish. As a result, Ms. Palmese’s practice includes both U.S. and international clients, and a significant portion of her practice is directed to the representation of Italian companies with respect to their intellectual property issues in the United States. | 